AXIS Capital (NYSE:AXS) Price Target Raised to $127.00

AXIS Capital (NYSE:AXS) had its price objective raised by equities researchers at TD Cowen from $118.00 to $127.00 in a research note issued to investors on Wednesday,Benzinga reports. The firm presently has a “buy” rating on the insurance provider’s stock. TD Cowen’s price target suggests a potential upside of 39.62% from the stock’s current price.

A number of other equities analysts have also recently commented on the company. Roth Mkm raised their target price on AXIS Capital from $75.00 to $90.00 and gave the company a “buy” rating in a report on Wednesday, July 31st. Wells Fargo & Company lifted their price objective on shares of AXIS Capital from $74.00 to $78.00 and gave the company an “underweight” rating in a report on Thursday, October 10th. Keefe, Bruyette & Woods increased their target price on shares of AXIS Capital from $94.00 to $96.00 and gave the stock an “outperform” rating in a report on Wednesday, November 6th. Jefferies Financial Group boosted their price target on shares of AXIS Capital from $88.00 to $95.00 and gave the stock a “buy” rating in a research note on Wednesday, October 9th. Finally, Bank of America increased their price objective on AXIS Capital from $81.00 to $96.00 and gave the company a “buy” rating in a research note on Thursday, October 10th. One analyst has rated the stock with a sell rating and seven have assigned a buy rating to the company’s stock. According to data from MarketBeat.com, the stock has a consensus rating of “Moderate Buy” and an average price target of $97.14.

AXIS Capital Stock Down 0.3 %

Shares of NYSE:AXS opened at $90.96 on Wednesday. The business has a 50-day moving average price of $81.93 and a 200 day moving average price of $76.20. AXIS Capital has a 12-month low of $53.49 and a 12-month high of $91.52. The company has a current ratio of 0.60, a quick ratio of 0.60 and a debt-to-equity ratio of 0.27. The company has a market capitalization of $7.61 billion, a price-to-earnings ratio of 12.62, a PEG ratio of 0.31 and a beta of 0.90.

AXIS Capital (NYSE:AXS) last posted its earnings results on Wednesday, October 30th. The insurance provider reported $2.71 earnings per share for the quarter, beating the consensus estimate of $2.55 by $0.16. AXIS Capital had a net margin of 10.82% and a return on equity of 19.24%. The firm had revenue of $1.61 billion during the quarter, compared to the consensus estimate of $1.57 billion. During the same quarter last year, the firm earned $2.34 EPS. Sell-side analysts expect that AXIS Capital will post 10.89 EPS for the current year.

Institutional Inflows and Outflows

Several institutional investors and hedge funds have recently made changes to their positions in the business. Versant Capital Management Inc grew its position in shares of AXIS Capital by 55.6% in the 2nd quarter. Versant Capital Management Inc now owns 462 shares of the insurance provider’s stock valued at $33,000 after buying an additional 165 shares during the last quarter. True Wealth Design LLC purchased a new position in shares of AXIS Capital during the third quarter worth about $40,000. GAMMA Investing LLC lifted its holdings in shares of AXIS Capital by 80.4% in the 2nd quarter. GAMMA Investing LLC now owns 507 shares of the insurance provider’s stock valued at $36,000 after purchasing an additional 226 shares during the last quarter. Point72 Asia Singapore Pte. Ltd. boosted its position in shares of AXIS Capital by 32.6% in the 2nd quarter. Point72 Asia Singapore Pte. Ltd. now owns 602 shares of the insurance provider’s stock valued at $43,000 after purchasing an additional 148 shares during the period. Finally, Blue Trust Inc. increased its position in AXIS Capital by 424.6% during the third quarter. Blue Trust Inc. now owns 1,217 shares of the insurance provider’s stock worth $97,000 after buying an additional 985 shares during the period. 93.44% of the stock is owned by institutional investors and hedge funds.

AXIS Capital Company Profile

AXIS Capital Holdings Limited, through its subsidiaries, provides various specialty insurance and reinsurance products in Bermuda, the United States, and internationally. It operates through two segments, Insurance and Reinsurance. The Insurance segment offers professional insurance products that cover directors' and officers' liability, errors and omissions, employment practices, fiduciary, crime, professional indemnity, medical malpractice, and other financial insurance related coverages for commercial enterprises, financial institutions, not-for-profit organizations, and other professional service providers; and property insurance products for commercial buildings, residential premises, construction projects, property in transit, onshore renewable energy installations, and physical damage and business interruption following an act of terrorism.